a NIAID-sponsored group of medical centers, known as AIDS Clinical Trials Units (ACTU), that evaluate treatments for HIV disease and associated illnesses. ACTG studies are designated by number (e.g., ACTG 019).
A network of medical centers around the country in which federally-funded clinical trials are conducted to test the safety and effectiveness of experimental treatments for AIDS and HIV infection. ACTG studies are sponsored by the National Institute of Allergy and Infectious Diseases (NIAID).
The AIDS Clinical Trials Group (ACTG) is the largest HIV clinical trials organization in the world, playing a major role in setting standards of care for HIV infection and opportunistic diseases related to HIV and AIDS in the United States and the developed world. The ACTG is composed of, and directed by, leading clinical scientists in HIV/AIDS therapeutic research. The ACTG is funded by the Department of Health and Human Services, National Institutes of Health through the National Institute of Allergy and Infectious Diseases.